Terlipressin Acetate Powder: A Breakthrough Vasopressin Analog for Hepatorenal Syndrome and Variceal Bleeding
Revolutionizing critical care with a proven solution for severe liver and kidney complications.
Get a Quote & SampleUnlocking the Therapeutic Power of Terlipressin
Terlipressin
Terlipressin is a cutting-edge, artificially synthesized long-acting vasopressin preparation. As a precursor drug, it uniquely releases active lysine vasopressin slowly within the body after enzymatic action. This controlled release mechanism ensures stable and sustained therapeutic effects, making it an invaluable asset in critical care settings for patients facing life-threatening conditions related to hepatic and renal dysfunction.
- Harnessing the power of Terlipressin Acetate for hepatorenal syndrome treatment, offering a vital pathway to improved patient outcomes.
- Explore the diverse Terlipressin peptide powder uses, extending beyond traditional applications to address complex medical needs.
- As a trusted long-acting vasopressin analog supplier, we provide high-purity Terlipressin for pharmaceutical applications worldwide.
- Our pharmaceutical peptide is rigorously tested for its high purity, ensuring effective and reliable clinical application of Terlipressin in liver disease management.
Product Advantages and Clinical Impact
Sustained Therapeutic Action
Terlipressin acts as a long-acting vasopressin precursor, enabling a stable and prolonged release of active lysine vasopressin, crucial for continuous therapeutic benefit in acute conditions.
Significant Survival Improvement
Clinical studies demonstrate that Terlipressin significantly prolongs survival time for HRS patients and is highly effective for esophageal variceal bleeding management, making it a critical intervention.
Enhanced Organ Function
This powerful pharmaceutical peptide improves liver and kidney function, providing essential support for patients suffering from severe hepatic and renal dysfunction.
Key Applications
Hepatorenal Syndrome Reversal
Terlipressin is specifically indicated for hepatorenal syndrome reversal, offering a vital treatment pathway to improve kidney function in severe liver disease patients.
Esophageal Variceal Bleeding Treatment
It stands as a first-line drug for esophageal variceal bleeding treatment, proven to effectively control hemorrhage and prolong patient survival.
Refractory Shock Management
Beyond liver conditions, Terlipressin also shows efficacy in refractory shock management, stabilizing hemodynamics when other vasoconstrictors fail.
Management of Liver Cirrhosis Ascites
It plays a role in the management of ascites due to liver cirrhosis, helping to reduce fluid accumulation and improve patient comfort and prognosis.